Your browser is no longer supported. Please, upgrade your browser.
MDT [NYSE]
Medtronic plc
IndexS&P 500 P/E48.13 EPS (ttm)2.66 Insider Own0.10% Shs Outstand1.35B Perf Week4.33%
Market Cap170.20B Forward P/E20.38 EPS next Y6.28 Insider Trans-4.93% Shs Float1.34B Perf Month2.38%
Income3.61B PEG4.40 EPS next Q1.32 Inst Own83.60% Short Float0.69% Perf Quarter-1.58%
Sales30.12B P/S5.65 EPS this Y-26.10% Inst Trans-0.27% Short Ratio2.16 Perf Half Y9.56%
Book/sh38.18 P/B3.35 EPS next Y10.56% ROA3.80% Target Price139.85 Perf Year32.92%
Cash/sh8.14 P/C15.73 EPS next 5Y10.94% ROE7.10% 52W Range94.64 - 132.30 Perf YTD9.33%
Dividend2.52 P/FCF96.43 EPS past 5Y0.80% ROI4.90% 52W High-3.20% Beta0.81
Dividend %1.97% Quick Ratio2.10 Sales past 5Y0.90% Gross Margin65.60% 52W Low35.33% ATR1.76
Employees90000 Current Ratio2.60 Sales Q/Q36.50% Oper. Margin13.90% RSI (14)56.39 Volatility1.42% 1.26%
OptionableYes Debt/Eq0.51 EPS Q/Q120.50% Profit Margin12.00% Rel Volume0.56 Prev Close128.54
ShortableYes LT Debt/Eq0.51 EarningsMay 27 BMO Payout86.60% Avg Volume4.29M Price128.07
Recom1.90 SMA201.40% SMA501.97% SMA2007.97% Volume2,397,078 Change-0.37%
Jun-10-21Resumed Cowen Outperform $141
May-25-21Initiated Barclays Equal Weight $145
Apr-15-21Initiated Atlantic Equities Overweight $153
Dec-15-20Upgrade Morgan Stanley Equal-Weight → Overweight $140
Dec-15-20Upgrade Goldman Sell → Neutral $100 → $119
Oct-08-20Upgrade Stifel Hold → Buy $125
Oct-08-20Upgrade Bernstein Mkt Perform → Outperform
Sep-11-20Initiated Wolfe Research Peer Perform $115
May-14-20Downgrade DZ Bank Buy → Hold $92
Mar-30-20Downgrade Needham Strong Buy → Buy $134 → $109
Mar-25-20Upgrade DZ Bank Hold → Buy $90
Mar-05-20Initiated Citigroup Buy $124
Feb-13-20Initiated Goldman Sell $118
Jan-08-20Initiated SunTrust Buy $130
Jan-02-20Upgrade Guggenheim Neutral → Buy $135
Jun-05-19Upgrade Wells Fargo Market Perform → Outperform
Feb-04-19Reiterated Needham Strong Buy $120 → $117
Jan-03-19Initiated Deutsche Bank Buy $99
Jan-02-19Downgrade Citigroup Buy → Neutral
Dec-19-18Upgrade JP Morgan Neutral → Overweight
Jul-26-21 12:24PM  
09:00AM  
05:00AM  
Jul-23-21 01:11PM  
Jul-22-21 02:16PM  
08:07AM  
Jul-20-21 09:50AM  
09:50AM  
Jul-16-21 07:11AM  
Jul-15-21 04:16PM  
03:16PM  
01:50PM  
04:04AM  
Jul-13-21 12:49PM  
09:39AM  
Jul-12-21 12:14PM  
Jul-08-21 10:36AM  
Jul-07-21 02:16PM  
10:13AM  
09:00AM  
09:00AM  
Jul-05-21 04:20PM  
Jun-30-21 02:41PM  
01:42PM  
09:37AM  
Jun-29-21 11:20AM  
09:00AM  
Jun-28-21 11:30AM  
09:56AM  
09:00AM  
06:39AM  
Jun-26-21 02:38PM  
07:36AM  
Jun-25-21 02:51PM  
02:33AM  
Jun-24-21 04:26PM  
06:52AM  
Jun-23-21 04:40PM  
04:36PM  
09:00AM  
09:00AM  
07:42AM  
Jun-22-21 08:00AM  
Jun-21-21 06:00PM  
10:00AM  
10:00AM  
Jun-19-21 04:52AM  
Jun-17-21 04:30PM  
Jun-14-21 02:25PM  
10:38AM  
Jun-11-21 01:42PM  
Jun-10-21 09:00AM  
Jun-09-21 08:00AM  
Jun-08-21 10:14AM  
07:11AM  
Jun-07-21 01:04PM  
10:15AM  
09:00AM  
Jun-03-21 09:13AM  
09:00AM  
07:30AM  
07:02AM  
06:45AM  
06:10AM  
Jun-02-21 12:30PM  
12:30PM  
07:31AM  
Jun-01-21 03:47PM  
10:02AM  
10:01AM  
10:01AM  
May-28-21 08:47AM  
07:30AM  
May-27-21 04:15PM  
04:00PM  
11:11AM  
10:55AM  
10:40AM  
10:05AM  
09:26AM  
08:05AM  
07:12AM  
06:45AM  
06:01AM  
May-26-21 09:00AM  
May-25-21 11:00AM  
11:00AM  
May-24-21 11:22AM  
09:41AM  
08:19AM  
04:31AM  
May-23-21 03:34AM  
May-20-21 03:00PM  
09:34AM  
May-18-21 02:44PM  
09:00AM  
08:00AM  
May-17-21 10:17AM  
May-14-21 09:00AM  
07:15AM  
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Medical Surgical Portfolio segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases. The Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Operating Unit segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Martha GeoffreyCEOJun 28Option Exercise55.3211,500636,18093,448Jun 30 06:21 PM
Martha GeoffreyCEOJun 28Sale125.2911,5001,440,83581,948Jun 30 06:21 PM
Wall Brett A.EVP & Pres NeuroscienceJun 21Sale123.5011514,20221,602Jun 22 05:58 PM
Wall Brett A.EVP & Pres NeuroscienceJun 18Option Exercise74.841,16887,41322,655Jun 22 05:58 PM
PARKHILL KAREN LEVP & Chief Financial OfficerJun 15Sale124.4760575,30486,223Jun 17 06:11 PM
Wall Brett A.EVP & Pres NeuroscienceJun 01Sale128.072,473316,71721,487Jun 02 06:00 PM
Liddicoat John REVP & President of AmericasMay 28Option Exercise82.7334,6562,866,92577,207Jun 01 05:55 PM
Wall Brett A.EVP & Pres NeuroscienceMay 28Option Exercise47.0012,300578,10031,315Jun 02 06:00 PM
Liddicoat John REVP & President of AmericasMay 28Sale126.6534,6564,389,18242,551Jun 01 05:55 PM
Martha GeoffreyCEOApr 05Option Exercise52.5011,712614,92591,246Apr 07 04:28 PM
Martha GeoffreyCEOApr 05Sale118.8311,7121,391,73781,938Apr 07 04:28 PM
PARKHILL KAREN LEVP & Chief Financial OfficerMar 15Sale119.1263275,28486,556Mar 16 05:19 PM
TEN HOEDT ROBEVP & President EMEAMar 02Option Exercise34.887,168250,02050,965Mar 03 05:23 PM
TEN HOEDT ROBEVP & President EMEAMar 02Sale117.987,168845,68143,797Mar 03 05:23 PM
Surface Carol ASVP, Chief HR OfficerDec 28Sale114.9015,0001,723,50034,150Dec 30 04:42 PM
Lerman Bradley ESVP General Counsel & Corp SecDec 22Sale115.562,605301,03451,543Dec 23 04:35 PM
WHITE ROBERT JOHNEVP & Pres. Medical SurgicalDec 18Sale115.4610,9301,261,97844,922Dec 21 05:06 PM
PARKHILL KAREN LEVP & Chief Financial OfficerDec 15Sale114.3367076,60186,897Dec 16 05:34 PM
Lerman Bradley ESVP General Counsel & Corp SecNov 09Option Exercise62.7620,7151,300,07374,863Nov 10 05:18 PM
Lerman Bradley ESVP General Counsel & Corp SecNov 09Sale113.1320,7152,343,48854,148Nov 10 05:18 PM
ISHRAK OMARExecutive ChairmanOct 09Sale108.4076382,709561,032Oct 14 06:38 PM
Lerman Bradley ESVP General Counsel & Corp SecOct 08Option Exercise62.7620,7141,300,01174,242Oct 09 05:12 PM
ANDERSON RICHARD HDirectorOct 08Buy108.524,607499,952101,673Oct 09 05:10 PM
Lerman Bradley ESVP General Counsel & Corp SecOct 08Sale110.0020,7142,278,54054,325Oct 09 05:12 PM
TEN HOEDT ROBEVP & President EMEASep 23Sale104.349,584999,99543,476Sep 25 05:42 PM
PARKHILL KAREN LEVP & Chief Financial OfficerSep 15Sale107.7870275,66287,366Sep 16 05:40 PM
TEN HOEDT ROBEVP & President EMEASep 09Sale105.059,5631,004,59353,060Sep 11 06:04 PM